Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter
YouTube

26°
- Broken Bow, NE (68822)
  Today
  
  Sunny. High around 30F. Winds W at 10 to 20 mph..
  
  Tonight
  
  Clear to partly cloudy. Low 14F. Winds W at 5 to 10 mph.
  
  Updated: December 1, 2025 @ 1:05 pm
- Full Forecast

Site search

Home
News
- Local News
Sports
Obituaries
Photos
Videos
e-Edition
Classifieds
Business Directory
Best of 2024

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Gilead Sciences (NQ:GILD)

124.14 -1.70 (-1.35%)

Streaming Delayed Price Updated: 3:15 PM EST, Dec 1, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Gilead Sciences

< Previous 1 2 3 4 5 6 7 8 9

...

48 49 Next >

5 Healthcare Names to Watch as Sector Rotation Is in Full Swing ↗

Today 10:51 EST

Via MarketBeat

Here's How Much $1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today ↗

November 28, 2025

Via Benzinga

Top S&P500 movers in Friday's session ↗

November 28, 2025

Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

These S&P500 stocks are moving in today's session ↗

November 28, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.

Via Chartmill

Merck Says Its Two-Drug Regimen For HIV Treatment Proven Non-Inferior To Gilead’s Biktarvy In Study ↗

November 19, 2025

Via Stocktwits

Vir Biotechnology Stock Set For Premarket Surge? Retail Trader Hopes Swell As ‘Phenomenal’ HDV Data Sets Stage For Gilead Showdown ↗

November 09, 2025

Via Stocktwits

Gapping S&P500 stocks in Friday's session ↗

November 28, 2025

Curious about the S&P500 stocks that are gapping on Friday? Explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Kymera (KYMR) Q3 2025 Earnings Call Transcript ↗

November 27, 2025

Kymera (KYMR) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Gilead Sciences Inc (NASDAQ:GILD) Demonstrates Strong Dividend Reliability and Profitability ↗

November 25, 2025

Gilead Sciences (GILD) is a reliable dividend stock with a 2.53% yield, 10-year payment history, and a low payout ratio. Strong profitability and a debt-free balance sheet support its sustainable...

Via Chartmill

$1000 Invested In Gilead Sciences 5 Years Ago Would Be Worth This Much Today ↗

November 20, 2025

Via Benzinga

Gilead Sciences Inc Chart Analysis ↗

November 19, 2025

Technical analysis on the stock chart for GILD.

Via Talk Markets

Merck's Investigational Two-Drug Regime Matches Gilead's Three-Drug Tablet For HIV Treatment ↗

November 19, 2025

Merck's HIV pill met key efficacy and safety goals in Phase 3 trials, matching Biktarvy as the FDA reviews its application with a 2026 decision date.

Via Benzinga

Wall Street Braces for Impact as Delayed Jobs Report Emerges from Data Blackout

November 19, 2025

New York, NY – November 19, 2025 – Wall Street is on high alert as the highly anticipated September 2025 jobs report, a critical barometer of the nation's economic health, is finally set to be released...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Uncover the latest developments among S&P500 stocks in today's session. ↗

November 18, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Gilead Sciences's Options: A Look at What the Big Money is Thinking ↗

November 17, 2025

Via Benzinga

Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty

November 14, 2025

As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

1 Healthcare Stock to Own for Decades and 2 We Avoid

November 13, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,...

Via StockStory

Topics Stocks

Tech Sector Tremors: Is the AI Bubble Deflating, and What's Next for the Market?

November 13, 2025

As of mid-November 2025, a palpable unease has settled over the technology sector, long the darling of investors and the primary engine of market growth. After a period of unprecedented outperformance,...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Gilead’s Experimental One Pill Regimen Proved Non-Inferior To Multi-Pill Regimens In Treating HIV ↗

November 13, 2025

The company now plans to submit the data from the study to regulatory authorities.

Via Stocktwits

Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial ↗

November 13, 2025

Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.

Via Benzinga

Explore the top gainers and losers within the S&P500 index in today's session. ↗

November 13, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.

Via Chartmill

2 Supercharged Dividend Stocks to Buy Now ↗

November 13, 2025

Innovative drugmakers often make for solid dividend stocks. These two companies are great examples.

Via The Motley Fool

Topics ETFs Intellectual Property

This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

November 13, 2025

Via Benzinga

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

Is the AI Rally a Bubble? Impact on Commodity Demand and Defensive Stock Rotation

November 11, 2025

As November 2025 unfolds, a subtle yet significant shift in market sentiment is becoming increasingly palpable among financial analysts and retail investors alike. What was once an almost universally...

Via MarketMinute

Topics Artificial Intelligence ETFs Economy

Healthcare Sector Navigates Turbulent Waters: Innovation Surges Amidst Political Headwinds

November 10, 2025

New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers...

Via MarketMinute

Topics Artificial Intelligence Economy Government

What's going on in today's session: S&P500 movers ↗

November 07, 2025

Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Gilead's Trodelvy Misses Main Goal In Breast Cancer Study But Shows Early Survival Trend ↗

November 07, 2025

Gilead's Trodelvy missed a key goal in breast cancer, while Livdelzi showed durable efficacy and safety in long-term liver disease studies.

Via Benzinga

Navigating the Volatility: Q3 2025 Earnings Season Delivers Both Cheers and Concerns

November 06, 2025

The third-quarter 2025 earnings season, largely drawing to a close in early November, has proven to be a dynamic and often surprising period for investors. While a significant majority of S&P 500...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High

November 06, 2025

San Diego, CA – November 6, 2025 – Ligand Pharmaceuticals (NASDAQ: LGND) has recently captured the financial spotlight, with its stock hitting a remarkable 52-week high of $197.78 on November 6, 2025....

Via MarketMinute

Topics Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

48 49 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Business
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Pay Your Bill
Classifieds
Promote Your Event
Email Alerts
Place an Ad
Rack Locations
Search
Weather

custercountychief.com
305 South 10th Avenue
Broken Bow, NE 68822
Phone: 308-872-2471
Email: publisher@custercountychief.com

Facebook
Twitter
YouTube

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Broken Bow, NE (68822)

Today

Tonight

Gilead Sciences (NQ:GILD)

Headline News about Gilead Sciences

Sections

Services

Follow Us